Sildenafil citrate

Sildenafil Citrate is the citrate salt form of sildenafil (erectile disfunction medicine), an orally bioavailable pyrazolopyrimidinone derivative structurally related to zaprinast, with vasodilating and potential anti-inflammatory activities. Upon oral administration, sildenafil selectively targets and inhibits cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), thereby inhibiting the PDE5-mediated degradation of cGMP found in smooth muscle and increasing cGMP availability. This results in prolonged smooth muscle relaxation in the corpus cavernosum of the penis, thereby causing vasodilation, blood engorgement and a prolonged penile erection. In the smooth muscle of the pulmonary vasculature, the increase in cGMP results in smooth muscle relaxation, vasodilation of the pulmonary vascular bed, relieving pulmonary hypertension and increasing blood flow in the lungs. Additionally, sildenafil may reduce airway inflammation and mucus production. It is grouped under the following drug class(es): PDE5 Inhibitors and Vasodilating agents. Its therapeutic use is listed as sexual dysfunction agents and urological agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Viagra, Revatio and Caverta. Its PubChem CID is 135413523.

CAS No 171599-83-0
Molecular Formula C28H38N6O11S
Molecular Weight 666.7 g/mol
Synonyms 5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid

Frequently Asked Questions